SA PRO
Free Account
Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
5 analysts·Limited coverage
60%
Rating Distribution
Strong Buy
00%
Buy
360%
Hold
120%
Sell
120%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 20% higher.

Bear Case
$6.00
+20%
Consensus
$6.00
+20%
Bull Case
$6.00
+20%
Price Range5 analysts
Low
Consensus
High
$6.00
$6.00
Current Target
Current Price
$5.00
Upside to Target
$1.00

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Dec 1, 2025Morgan Stanley
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
Target:$6.00
+12.6%from $5.33
Mar 4, 2025Piper Sandler
Cytek Biosciences price target lowered to $8 from $8.25 at Piper Sandler
Target:$8.00
+85.6%from $4.31
Feb 2, 2025Goldman Sachs
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs
Target:$5.25
+1.9%from $5.15
May 13, 2024Piper Sandler
Cytek Biosciences Inc (CTKB) PT Lowered to $8.50 at Piper Sandler
Target:$8.50
+38.2%from $6.15
Aug 17, 2022Piper Sandler
Cytek Biosciences price target raised to $16 from $12 at Piper Sandler
Target:$16.00
+13.6%from $14.08
May 15, 2022Piper Sandler
Cytek Biosciences price target lowered to $12 from $17 at Piper Sandler
Target:$12.00
+27.9%from $9.38

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance